These tumors can arise de novo or can be associated with other myeloid disorders -- acute myeloid ... In this case, the granulocytic sarcoma was a large destructive pelvic tumor that caused ...

Optimal TKI therapy, like nilotinib, can lead to deep molecular responses and potential treatment-free remission in CML patients. Azurity provides a support program, DanzitenCONNECT, offering co ...

If a biopsy is needed, consulting with a specialist is essential for accurate diagnosis and treatment planning. Innovations ...

Annamycin is currently in development for the treatment of relapsed or refractory acute myeloid leukemia (AML) and soft tissue sarcoma (STS) lung metastases. Additionally, the Company is ...

Clinical Development Update Annamycin is currently being evaluated in ongoing clinical trials for the treatment of relapsed or refractory acute myeloid leukemia (AML) and soft tissue sarcoma (STS ...